RenovoRx, Inc.
- Last sale
- Nov 12, 2026 · -5.69%
- Market cap
- $55.97M
- 48.25M shares
- Filings
- 293
Q3 2026+2,511.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−1.8% FY25 yoy
- $55.97M
- —
- 20.2×
- 6.0×
- -21.84%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,123,000 | reported | |
| FY 2024 | 2024-12-31 | $43,000 | reported |
Surgical & medical instruments & apparatus
RenovoRx, Inc. is the 107th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
VYCOVycor Medical Inc$1.9M17.2%3.9%$3.0MEBRCZEBR Systems, Inc.$1.6M—3,015.3%—ICUSeaStar Medical Holding Corp$1.2M814.1%984.6%$5.6MPETVPetVivo Holdings, Inc.$1.1M0.8%917.4%$25.8M
RNXTRenovoRx, Inc. (this company)$1.1M2,511.6%994.5%$56.0M
SINTSintx Technologies, Inc.$1.0M64.7%1,018.1%$11.6MVJETFlyte Aviation, Inc.$819.0K95.0%2,098.0%$7.6MHRGNHarvard Apparatus Regenerative Technology, Inc.$704.0K63.7%975.7%$27.3MCODXCo-Diagnostics, Inc.$622.5K84.1%7,533.6%$2.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR